CAMLINFINENSECamlin Fine Sciences LimitedMinimalNeutral
Announced Wed, 27 May · 12:53 IST

Camlin Fine Sciences Limited has informed the Exchange about Copy of Newspaper Publication

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹121.50
prior close
₹128.39
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.2+0.4+0.5+0.8-2.9-2.1-3.6-1.2+4.7+12.8+6.9+5.2
Up moveDown movePending
AI summary

Camlin Fine Sciences has published its audited financial results for the quarter and year ended March 31, 2026. On a standalone basis, total income from operations was ₹837.92 crore for FY2026, down from ₹886.49 crore in FY2025. The company reported a net loss of ₹32.97 crore for FY2026, an improvement compared to a net loss of ₹76.31 crore in the previous year. On a consolidated basis, total income was ₹1,723.31 crore with a net profit of ₹23.54 crore for FY2026, a significant recovery from a net loss of ₹158.12 crore in FY2025. Basic EPS on consolidated basis was ₹1.46 for FY2026.

Likely market impact

The results show the company is on a recovery path with significantly narrowed losses on standalone and return to profit on consolidated basis. The improvement in bottom-line performance despite lower revenue is a positive signal for shareholders.